Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$339K Sell
937
-145
-13% -$49.6K 0.05% 156
2026
Q1
$381K Sell
1,082
-74
-6% -$26.4K 0.06% 140
2025
Q4
$378K Buy
1,156
+48
+4% +$15.2K 0.06% 138
2025
Q3
$313K Sell
1,108
-2
-0.2% -$580 0.05% 144
2025
Q2
$310K Sell
1,110
-244
-18% -$69.1K 0.06% 136
2025
Q1
$353K Sell
1,354
-1
-0.1% -$295 0.06% 125
2024
Q4
$437K Hold
1,355
0.08% 116
2024
Q3
$437K Sell
1,355
-87
-6% -$28.5K 0.08% 117
2024
Q2
$451K Sell
1,442
-982
-41% -$288K 0.09% 118
2024
Q1
$689K Buy
2,424
+120
+5% +$35.1K 0.14% 90
2023
Q4
$664K Buy
2,304
+31
+1% +$8.45K 0.13% 88
2023
Q3
$611K Sell
2,273
-7
-0.3% -$1.75K 0.14% 85
2023
Q2
$506K Sell
2,280
-315
-12% -$73.1K 0.11% 99
2023
Q1
$627K Buy
2,595
+112
+5% +$27.5K 0.14% 85
2022
Q4
$652K Buy
2,483
+83
+3% +$22.2K 0.14% 83
2022
Q3
$541K Buy
2,400
+126
+6% +$30.5K 0.13% 83
2022
Q2
$553K Hold
2,274
0.12% 91
2022
Q1
$550K Hold
2,274
0.11% 103
2021
Q4
$512K Sell
2,274
-25
-1% -$5.28K 0.1% 106
2021
Q3
$489K Buy
2,299
+4
+0.2% +$921 0.11% 109
2021
Q2
$559K Buy
2,295
+6
+0.3% +$1.48K 0.12% 97
2021
Q1
$570K Buy
2,289
+148
+7% +$35.3K 0.13% 92
2020
Q4
$492K Buy
2,141
+1,007
+89% +$232K 0.12% 88
2020
Q3
$288K Hold
1,134
0.08% 110
2020
Q2
$267K Hold
1,134
0.07% 122
2020
Q1
$230K Hold
1,134
0.07% 121
2019
Q4
$273K Sell
1,134
-207
-15% -$45.6K 0.06% 124
2019
Q3
$259K Buy
+1,341
New +$257K 0.06% 129
2019
Q1
Sell
-273
Closed -$53K 167
2018
Q4
$53K Buy
+273
New +$53.3K 0.01% 257
2018
Q2
Sell
-271
Closed -$46K 147
2018
Q1
$46K Buy
+271
New +$49.7K 0.01% 233

Other funds holding AMGN

Well Done LLC's AMGN Position: Q2 2026 in Review

Well Done LLC reduced its Amgen (AMGN) stake by 13% in Q2 2026, selling an estimated $49.6K and leaving 937 shares worth $339K. The position accounts for 0.05% of the portfolio, ranked #156.

Well Done LLC first reported a position in AMGN in Q1 2018 and has held it in 30 quarters since. The position peaked at $689K in Q1 2024. 1,315 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Well Done LLC held 937 shares of Amgen worth $339K as of Q2 2026.
  • Well Done LLC sold 145 Amgen shares in Q2 2026, an estimated $49.6K.
  • Amgen made up 0.05% of Well Done LLC's portfolio in Q2 2026, its #156 holding.
  • Well Done LLC first reported a position in Amgen in Q1 2018 and has held it in 30 quarters since.
  • Well Done LLC's Amgen position peaked at $689K in Q1 2024.
  • 1,315 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Well Done LLC's 13F filing for Q2 2026, filed 24 Jul 2026.